SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-047542
Filing Date
2019-08-27
Accepted
2019-08-27 16:55:11
Documents
1
Period of Report
2019-08-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18951
  Complete submission text file 0001209191-19-047542.txt   20371
Mailing Address C/O ARBUTUS BIOPHARMA CORP. 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
KARBE FRANK (Reporting) CIK: 0001276700 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 191058120

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44(0)207 400 3347
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations